Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

被引:94
作者
Morrow, David A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
angina; atherosclerosis; myocardial infarction; prevention; prognosis; C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; FOLLOW-UP; SCIENTIFIC STATEMENT; DIABETIC-PATIENTS; AMERICAN-COLLEGE;
D O I
10.1161/CIRCULATIONAHA.109.852749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment is essential to effective medical decision making for secondary prevention. A variety of clinical tools, including the most basic elements of the clinical history and the physical examination, provide valuable information on prognosis. In addition, data from the ECG, laboratory testing, and noninvasive and invasive imaging are complementary with respect to prognosis and can aid in informing patients and their families, directing triage, and guiding medical therapy. An integrated approach to risk assessment is optimal, and simple clinical risk scores can assist the clinician in assimilating the diverse sources of data on prognosis. Emerging tools for risk assessment continue to provide new insights into the pathogenesis of atherothrombosis and may advance the extent to which the promise of personalized preventive medicine can be realized in our routine care of patients with CV disease. Although discussed in the context of CHD, these principles are important to the full spectrum of patients with peripheral and cerebrovascular atherosclerotic disease. © 2010 American Heart Association, Inc.
引用
收藏
页码:2681 / 2691
页数:11
相关论文
共 82 条
[41]  
La Rovere MT, 1998, LANCET, V351, P478
[42]   Early detection and diagnosis of acute myocardial infarction: the potential for improved care with next-generation, user-friendly electrocardiographic body surface mapping [J].
Lefebvre, Cedric ;
Hoekstra, James .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2007, 25 (09) :1063-1072
[43]   Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes -: A fragmin and fast revascularisation during instability in coronary artery disease (FRISC)-II substudy [J].
Lindahl, B ;
Lindbäck, J ;
Jernberg, T ;
Johnston, N ;
Stridsberg, M ;
Venge, P ;
Wallentin, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (04) :533-541
[44]   Long-term risk stratification for survivors of acute coronary syndromes - Results from the long-term intervention with pravastatin in ischemic disease (LIPID) study [J].
Marschner, IC ;
Colquhoun, D ;
Simes, RJ ;
Glasziou, P ;
Harris, P ;
Singh, BB ;
Friedlander, D ;
White, H ;
Thompson, P ;
Tonkin, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (01) :56-63
[45]   Early versus Delayed Invasive Intervention in Acute Coronary Syndromes [J].
Mehta, Shamir R. ;
Granger, Christopher B. ;
Boden, William E. ;
Steg, Philippe Gabriel ;
Bassand, Jean-Pierre ;
Faxon, David P. ;
Afzal, Rizwan ;
Chrolavicius, Susan ;
Jolly, Sanjit S. ;
Widimsky, Petr ;
Avezum, Alvaro ;
Rupprecht, Hans-Jurgen ;
Zhu, Jun ;
Col, Jacques ;
Natarajan, Madhu K. ;
Horsman, Craig ;
Fox, Keith A. A. ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21) :2165-2175
[46]   Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarttion - B-Type natriuretic peptide and prognosis in TACTICS-TIMI 18 [J].
Morrow, DA ;
de Lemos, JA ;
Sabatine, MS ;
Murphy, SA ;
Demopoulos, LA ;
DiBattiste, PM ;
McCabe, CH ;
Gibson, CM ;
Cannon, CP ;
Braunwald, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) :1264-1272
[47]   A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy [J].
Morrow, DA ;
Antman, EM ;
Giugliano, RP ;
Cairns, R ;
Charlesworth, A ;
Murphy, SA ;
de Lemos, JA ;
McCabe, CH ;
Braunwald, E .
LANCET, 2001, 358 (9293) :1571-1575
[48]   TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy [J].
Morrow, DA ;
Antman, EM ;
Charlesworth, A ;
Cairns, R ;
Murphy, SA ;
de Lemos, JA ;
Giugliano, RP ;
McCabe, CH ;
Braunwald, E .
CIRCULATION, 2000, 102 (17) :2031-2037
[49]   An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes - Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS [J].
Morrow, DA ;
Antman, EM ;
Snapinn, SM ;
McCabe, CH ;
Theroux, P ;
Braunwald, E .
EUROPEAN HEART JOURNAL, 2002, 23 (03) :223-229
[50]   New insight into clinical risk scores for patients with acute coronary syndromes [J].
Morrow, DA .
AMERICAN HEART JOURNAL, 2003, 146 (05) :754-756